Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.10 (6.25%)
Bid:
1.55
Ask:
1.85
Spread: 0.30 (19.355%)
Market Cap: £264.88k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Corporate Update

6 Jan 2023 08:10

RNS Number : 9341L
Iconic Labs PLC
06 January 2023
 

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Corporate Update

 

 

Iconic Labs PLC (LSE:ICON), a multi-divisional new media and technology business, is pleased to provide the following corporate update.

 

The Iconic Board is mindful that the recently published accounts of the Company for the years ended 30 June 2021 and 30 June 2022 (the "Accounts") contain a lot of information to digest, particularly because it was not possible for the Company to communicate with the market for several months while the administration was pending.

As such, the Board wishes to make certain points clear:

· The administration has now completed, and control of the Company has been returned to the Board.

 

· Iconic and its advisers are in active ongoing dialogue with the Financial Conduct Authority ("FCA") to lift the suspension of the listing of its shares (the "Suspension") as soon as possible.

 

· All disputes involving the Company, the former management of the Company, and European High Growth Opportunities Securitization Fund ("EHGOSF") have been resolved.

 

· Iconic signed a £3,000,000 financing facility with EHGOSF to pay for the Company's short term operational needs and the Company Voluntary Arrangement ("CVA") requirements. After drawing down 3 tranches under this facility, as noted in the Accounts, the Company cannot draw down any more funds until the Suspension is lifted. 

 

· The key provisions under the CVA are as follows:

 

Administration fees and preferential and critical creditors are being paid under a payment plan that will end in April or May of this year if the Company can continue to access the funds under the EHGOSF financing facility.

 

Unsecured creditors agreed to a 75% discount in their claims against the Company (a reduction from approximately £1,070,000 to £267,000) to be satisfied through the issue of 1,674,130,609 new ordinary shares in the Company, if the CVA payment obligations referenced above can be met.

 

Secured creditor claims brought against Iconic of roughly £4,200,000 were reduced to £750,000 to be satisfied through the issue of convertible notes.

 

EHGOSF reduced its claims against Iconic of £3,000,000 down to £750,000 to be satisfied through the issue of convertible notes.

Now that the Company has been successfully restructured, it is in a much better position than it was when the listing was suspended in June of 2021.

The Company will keep the market informed as matters progress regarding lifting the Suspension and any corporate developments.

 

ENQUIRIES:

ir@iconiclabs.co.uk

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDNKABKFBKKADK
Date   Source Headline
2nd Jun 20265:18 pmRNSConversion of Notes and Allotment of Shares
29th May 20267:00 amRNSTotal Voting Rights
29th Apr 202612:58 pmRNSConversion of Notes and Allotment of Shares
31st Mar 20267:00 amRNSInterim Results
27th Feb 202610:23 amRNSTotal Voting Rights
23rd Feb 20267:00 amRNSConversion of Notes and Allotment of Shares
31st Dec 202511:37 amRNSResult of AGM
8th Dec 20252:16 pmRNSNotice of AGM
23rd Oct 20252:30 pmRNSFull Year Results
12th Aug 20252:04 pmRNSUpdate on Compliance with UK Listing Rules
30th Jun 20253:27 pmRNSHolding(s) in Company
30th Jun 20253:25 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSTotal Voting Rights
9th Jun 20254:28 pmRNSConversion of Notes and Allotment of Shares
6th Jun 20259:48 amRNSConversion of Notes and Allotment of Shares
3rd Jun 20252:54 pmRNSConversion of Notes and Allotment of Shares
30th May 20254:00 pmRNSConversion of Notes and Allotment of Shares
28th May 20255:24 pmRNSConversion of Notes and Allotment of Shares
28th May 20254:54 pmRNSHolding(s) in Company
28th May 20254:52 pmRNSHolding(s) in Company
28th May 20254:50 pmRNSHolding(s) in Company
28th May 20254:48 pmRNSHolding(s) in Company
20th May 20257:30 amRNSRestoration Iconic Labs Plc
20th May 20257:00 amRNSRestoration of Trading and Funding Update
15th May 20254:18 pmRNSResult of AGM
24th Apr 20255:16 pmRNSNotice of AGM
31st Mar 20256:41 pmRNSInterim Results
31st Mar 20255:26 pmRNSRevised Results for the Year ended 30 June 2024
13th Feb 20255:55 pmRNSTransaction Terminated
7th Feb 20252:52 pmRNSNotification of Major Holdings
31st Oct 20243:57 pmRNSFull Year Results for the Year ended 30 June 2024
9th Sep 20247:00 amRNSWaiver of Event of Default
10th Jul 20244:22 pmRNSBoard Changes
28th Mar 20247:00 amRNSInterim Results
11th Mar 202412:00 pmRNSHeads of Terms Signed
29th Feb 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSSuspension of Trading
13th Feb 20242:08 pmRNSResult of AGM
7th Feb 20249:10 amRNSConversion of Notes and Allotment of Shares
19th Jan 20243:49 pmRNSNotice of AGM
4th Jan 20247:00 amRNSBoard Changes & Business and Strategy Update
29th Dec 20237:00 amRNSTotal Voting Rights
7th Dec 20238:53 amRNSConversion of Securities
4th Dec 20237:53 amRNSConversion of Securities
30th Nov 20237:00 amRNSTotal Voting Rights
17th Nov 202311:32 amRNSConversion of Securities
13th Nov 20238:40 amRNSConversion of Securities
2nd Nov 202310:35 amRNSConversion of Securities
31st Oct 20239:29 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSFull Year Results for the Year ended 30 June 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.